Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 9/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 7/20 | 0.35 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.35 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | HRH2 | P25021 | 1/20 | 0.34 |
| ▸ | HRH1 | P35367 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 2/20 | 0.33 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | CNR1 | P21554 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | SCARB1 | Q8WTV0 | 1/20 | 0.32 |
| ▸ | P4HB | P07237 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25517137 | 0.88 | CNR2 (0.41) | CNR2KMT2AMAPTALDH1A1CNR1 | |
| SCHEMBL25515739 | 0.88 | KMT2A (0.41) | CNR2KMT2APLA2G1BATG4BMAPT | |
| SCHEMBL25516687 | 0.84 | CNR2 (0.44) | CNR2MAPTCNR1HPGD | |
| SCHEMBL25517063 | 0.84 | CNR2 (0.44) | CNR2MAPTCNR1HPGD | |
| SCHEMBL25520088 | 0.82 | CNR2 (0.39) | CNR2MAPTCNR1HPGDSCARB1 | |
| SCHEMBL25520089 | 0.82 | CNR2 (0.39) | CNR2MAPTCNR1HPGDSCARB1 | |
| SCHEMBL25516849 | 0.81 | CNR2 (0.43) | CNR2MAPTALDH1A1CNR1HPGD | |
| SCHEMBL25518559 | 0.80 | CNR2 (0.37) | CNR2MAPTHRH2HRH1CNR1 | |
| SCHEMBL23801805 | 0.79 | KMT2A (0.41) | CNR2KMT2APLA2G1BATG4BMAPT | |
| SCHEMBL25517135 | 0.77 | CNR2 (0.45) | CNR2KMT2AHRH2HRH1CNR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230142648-A1 | OXIME ESTER PHOTOINITIATORS | BASF SE (DE) | 2023-05-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230142648-A1 | OXIME ESTER PHOTOINITIATORS | OCIAD1, OCIAD2, OXER1 | CNR2 663/4885KMT2A 3437/4885PLA2G1B 3031/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.